Médicaments : Les Profits de la pénurie

Médicaments : Les Profits de la pénurie

Release date : April 19, 2022
Runtime : 1h 30m
Countries of origin : France /
Original Language : French /
Director : Xavier Deleu /
Writers :
Production companies : ARTE / Découpages /
April 19, 2022 1h 30m France Documentary French More
6.5
User Score

Overview

Injectable anti-inflammatories, anticoagulants, anti-infectives, anticancer drugs and even cotton wools are in short supply. Like many others in France, the pharmacy at Rennes hospital is constantly on the edge. Over the past two decades, shortages of medicines and health products have increased twentyfold in Europe. With almost all laboratories affected, practitioners and health establishments are forced to juggle with quotas to make up for shortages. Some even have to prioritise patients in terms of access to treatments, according to scales established by the laboratories. In the Netherlands, hospital pharmacies have resigned themselves to manufacturing the molecules they lack.
More »

Top Billed Cast

More

Images

View All Images

Recommendations

More
The Garden of Sinners: Paradox Spiral
Action Animation Drama Mystery Thriller Fantasy
Japon İşi
Comedy Science Fiction
Ong Bak 3
Action Adventure History
Hunter × Hunter Pilot
Animation Action Adventure Fantasy
Young and Dangerous 5
Action Crime Thriller
Moscow 1996, Vote or Lose!
Documentary History TV Movie
Don't Blink
Horror Mystery
  • title:Médicaments : Les Profits de la pénurie
  • status:Released
  • Release date: 2022
  • Runtime:1h 30m
  • Genres: Documentary · TV Movie ·
  • Countries of origin: France ·
  • Original Language: French ·
  • Director: Xavier Deleu /
  • Writers:
  • Production companies: ARTE · Découpages ·
  • Overview:Injectable anti-inflammatories, anticoagulants, anti-infectives, anticancer drugs and even cotton wools are in short supply. Like many others in France, the pharmacy at Rennes hospital is constantly on the edge. Over the past two decades, shortages of medicines and health products have increased twentyfold in Europe. With almost all laboratories affected, practitioners and health establishments are forced to juggle with quotas to make up for shortages. Some even have to prioritise patients in terms of access to treatments, according to scales established by the laboratories. In the Netherlands, hospital pharmacies have resigned themselves to manufacturing the molecules they lack.
Search history
delete
Popular search